Genomic characteristics of homologous recombination deficiency in ovarian cancer.

被引:0
|
作者
Ma, Xiaoxue [1 ]
Li, Mingwei [1 ]
Lou, Feng [1 ]
Cao, Shanbo [1 ]
Wang, Huina [1 ]
机构
[1] Acornmed Biotechnol Co Ltd, Beijing, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e17575
引用
收藏
页码:E17575 / E17575
页数:1
相关论文
共 50 条
  • [1] Genomic characteristics of homologous recombination deficiency in prostate cancer.
    Wei, Yu
    Yao, Zhu
    Cui, Lina
    Zhao, Xiaochen
    Bai, Yuezong
    Ye, Dingwei
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [2] Genomic signatures as predictive biomarkers of homologous recombination deficiency in ovarian cancer
    Vanderstichele, Adriaan
    Busschaert, Pieter
    Olbrecht, Siel
    Lambrechts, Diether
    Vergote, Ignace
    EUROPEAN JOURNAL OF CANCER, 2017, 86 : 5 - 14
  • [3] Homologous recombination deficiency and ovarian cancer
    Ledermann, Jonathan A.
    Drew, Yvette
    Kristeleit, Rebecca S.
    EUROPEAN JOURNAL OF CANCER, 2016, 60 : 49 - 58
  • [4] Homologous recombination deficiency in epithelial ovarian cancer
    Bartl, Thomas
    Paspalj, Valentina
    Grimm, Christoph
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2020, 13 (04) : 367 - 370
  • [5] Evaluation of Homologous Recombination Deficiency in Ovarian Cancer
    Ratnaparkhi, Rubina
    Javellana, Melissa
    Jewell, Andrea
    Spoozak, Lori
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2024, 25 (02) : 237 - 260
  • [6] Homologous recombination deficiency in epithelial ovarian cancer
    Thomas Bartl
    Valentina Paspalj
    Christoph Grimm
    memo - Magazine of European Medical Oncology, 2020, 13 : 367 - 370
  • [7] Evaluation of Homologous Recombination Deficiency in Ovarian Cancer
    Rubina Ratnaparkhi
    Melissa Javellana
    Andrea Jewell
    Lori Spoozak
    Current Treatment Options in Oncology, 2024, 25 : 237 - 260
  • [8] Assessment of Homologous Recombination Deficiency in Ovarian Cancer
    Garg, Vikas
    Oza, Amit M.
    CLINICAL CANCER RESEARCH, 2023, 29 (16) : 2957 - 2960
  • [9] CLINICAL CHARACTERISTICS AND GENOMIC BIOMARKERS OF THE HOMOLOGOUS RECOMBINATION DEFICIENCY PHENOTYPE IN HIGH-GRADE SEROUS OVARIAN CANCER
    Vanderstichele, A.
    Nulens, K.
    Busschaert, P.
    Van Nieuwenhuysen, E.
    Han, S.
    Concin, N.
    Neven, P.
    Berns, E.
    Braicu, I.
    Castillo-Tong, A. Cacsire
    Mahner, S.
    Sehouli, J.
    Zeillinger, R.
    Smeets, D.
    Lambrechts, D.
    Vergote, I.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1818 - 1818
  • [10] Genomic structural instability and homologous recombination deficiency in breast and ovarian cancers
    Popova, T.
    Manie, E.
    Battistella, A.
    Sastre-Garau, X.
    Goundiam, O.
    Vincent-Salomon, A.
    Stoppa-Lyonnet, D.
    Stern, M. H.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S101 - S101